Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
RYZODEG (insulin degludec and insulin aspart) is a drug prescribed to improve blood glucose control in diabetes mellitus. RYZODEG is an insulin product that lowers blood sugar to normal levels.
People with diabetes may have blood sugar that is too high (hyperglycemia) or too low (hypoglycemia). Insulin products can treat hyperglycemia.
RYZODEG contains two different types of insulin: basal insulin and mealtime insulin. RYZODEG is good for people that want to reduce the number of insulin injections they have per day.
Inject RYZODEG 70/30 subcutaneously once or twice daily with the largest meal(s) of the day. Rotate injection sites to decrease the risk of lipodystrophy and localized cutaneous amyloidosis.
The dosage of RYZODEG 70/30 will be determined by the doctor.
RYZODEG contains 70% insulin degludec, long-acting basal insulin. It also contains 30% insulin aspart, mealtime insulin with a fast onset.
Some medications can mask the signs and symptoms of hypoglycemia. Use caution when taking the following with insulin:
Certain medications can raise or lower blood sugar. Tell your doctor or pharmacist if you are taking any of the following:
The dosage of RYZODEG injection should not be adjusted more often than 3 to 4 days.
RYZODEG cannot be mixed with other insulin products.
Do not share insulin pens between patients, even if the pen needle is changed.
Blood sugar should be frequently monitored while taking insulin.
Check the product label before administration to reduce the risk of medication errors.
Your doctor may need to monitor potassium levels, kidney function, and liver function while taking insulin.
The most common side effects of RYZODEG 70/30 include:
Ryzodeg 70/30 [package insert]. Plainsboro, NJ: Novo Nordisk; 2019.